The topic was presented at the Annual DIA Japan meeting on November 7, 2013, by Theresa Mullin, PhD, FDA's director of the Office of Strategic Program, CDER. Dr. Mullin recommended preserving four strengths of ICH on approaching the future:  commitment of significant staff resources, commitment to ICH meetings, commitment to implementation of ICH guidelines and commitment to of resources to help train others to enable implementation of ICH guidelines. The presentation can be viewed and downloaded from the FDA website.